EIT Health Wild Card 2021 is a program that builds game-changing life science companies. Beginning with two challenges set by EIT Health, the annual Wild Card programme invites talented innovators, teams and individuals from across Europe to respond with their ideas or to put forward their skills and experience.
The teams selected to become Wild Card companies benefit from unique opportunities for an initial start-up. In this way, up to two teams receive two years of continuous support and up to €1.5 million in non-dilutive funding (€750,000/company/year), advice and coaching to help them grow their projects to market.
The deadline for submitting applications is 15 May 2021.